Posts Tagged ‘CanadaDrugs’
Canadian Citizen & Online Pharmacy Entrepreneur Sentenced to 4 Years in Counterfeit Drugs Case
View larger map Canadian citizen Andrew Strempler, 38, was arrested in Florida in June 2012 and was charged with conspiracy to commit wire fraud and mail fraud in the United States. In October of that year, he pled guilty to those charges. On January 9th, 2013, Andrew Strempler was sentenced to four years in…
[...]The Year in Review – Part 1 – Fake Medications in Doctors’ Offices
Fake Medications in Medical Offices
In the past two years, fake doctors were convicted of vitally
endangering the lives of patients who submitted to counterfeit treatments. Patients can keep themselves safe from fake doctors by checking the validity of their physician’s license with the state medical board. But patients can’t use proof of a valid physician’s license to protect themselves when real doctors administer fake medications. In the same time period, while two fake doctors were convicted of administering fake drugs to patients, three real doctors were convicted of the same crime.
Doctor Pleads Guilty in Misbranded Cancer Drug Case
US
Department of Justice convicts two in cases tying counterfeit cancer drugs
to Canadian pharmacy business.
On
November 15th, Dr. William Kincaid, of Johnson City, TN, was convicted for
knowingly purchasing non-FDA approved injectable cancer medications from
Quality Specialty Products (QSP). Dr. Kincaid accepted a plea deal with the
federal government in exchange for assisting them with their ongoing
investigation. Previously, Dr. Kincaid’s business manager, Michael Dean Combs
pled guilty in the same case on September 19th, reports
Knox News.
Who is the Criminal Mastermind Behind the Counterfeit Cancer Drug Scare?
In February and March 2012, the Food and Drug Administration announced fake cancer drugs had infiltrated the secure US drug supply chain. The investigation into who sold these drugs to US doctors in ongoing.
Seventy-six doctors in twenty-two states were contacted by the FDA because they may have purchased counterfeit Avastin from a “little-known drug wholesaler, Montana Healthcare Solutions,” reported the Wall Street Journal.
WSJ Connects Counterfeit Avastin Incidents to Canadadrugs.com
In February of this year, the FDA notified 19 cancer doctors that a counterfeit version of the cancer drug Avastin had breached the U.S.’s closed, secure drug supply chain. Now 5 months later, investigations have allegedly connected the counterfeit cancer drug’s entry into the US with one of Canada’s biggest online pharmacy operations, Canadadrugs.com.
[...]Canadian Online Pharmacy Owner Indicted in US Federal Court for Selling Counterfeit Drugs To Americans
Canadian citizen Andrew Strempler, 38, founder of Mediplan, which fulfilled online medicine orders for ten websites, appeared in federal court in Miami on Thursday, June 14, 2012. He is expected to be arraigned on charges related to a 2005 seizure of drugs shipped by Mediplan into the US. The medications were purported to be Canadian, but US FDA officials claim the medications were actually from other countries, reports the Canadian Broadcasting Corp (CBC).
[...]“Moving Beyond the Avastin Incident”: PSM Counterfeit Drug Congressional Briefing held on March 15
Partnership for Safe Medicines sponsored a Congressional Briefing to explore the continued impact of counterfeit drugs on Thursday, March 15 in the Capitol Visitor Center at noon.
[...]MHRA – FDA Cooperation Rousts Counterfeit Cancer Drugs
Cooperation between the U.K.’s Medicines and Healthcare Products Regulatory Agency and the USFDA brought the counterfeit Avastin distribution to light in the U.S. when MHRA officials let U.S. Food and Drug Administration agents know in December that they suspected the problem.
MHRA officials notified U.S. agents and Roche, which led Roche to test and confirm the vital life-saving medication as counterfeit last week, reported Reuters.
“As tragic as this incident is, it is to the credit of the manufacturer and law enforcement that they’ve been able to track down the source of the supplier of the counterfeit medication and contact their other customers. In many countries counterfeits make their way to patients without anyone ever being held accountable,” said Partnership for Safe Medicine’s board member Tom Kubic, President and CEO of the Pharmaceutical Security Institute.
Connie Jung, of the FDA’s Office of Drug Security, said it was possible that more than the 19 originally notified practices could be involved and warned that if a price appears to be too good to be true, it probably is.
Sources say that Montana Health Care Solutions sold the vials for 25% less than the expected cost, reports ABC World News.
Patients are beginning to be aware of the counterfeits, with growing outrage.
Said cancer patient Diane Barraza to ABC World News, “To sit in the chemo chair and watch that stuff drop into my veins,” who lives in Fullerton, Calif., with her 6-year-old daughter. “It’s all I’ve got. And it might just be water?”
FDA Warns 19 Medical Practices: Foreign Medical Distributor Gave Out Fakes, Including Fake Cancer Drugs
The FDA has issued letters to 19 US medical practices that purchased medication from a foreign supplier, Quality Specialty Products (QSP), warning that drugs distributed by QSP are known to be unapproved by the FDA, and in at least one instance verified counterfeit.
QSP, also known as Montana Health Care Solutions, has been identified by the FDA as the distributor of counterfeit Avastin. Roche AG, the manufacturer, has said that the counterfeit Avastin was tested and found to contain no active ingredient. Avastin is FDA approved for use in metastatic colorectal cancer, advanced nonsquamous non–small cell lung cancer, metastatic kidney cancer, and glioblastoma.
[...]FDA Alert: Counterfeit Version of Avastin in U.S. Distribution
This is a reprint of the FDA Safety Alert. FDA sends letters to 19 medical practices about counterfeit product and other unapproved cancer medicines The U.S. Food and Drug Administration (FDA) is warning health care professionals and patients about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by some medical…
[...]